Citation: Yang Liu, Jing Liang, Mengzhu Zheng, Haoze Song, Lixia Chen, Hua Li. PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity[J]. Chinese Chemical Letters, ;2025, 36(6): 110317. doi: 10.1016/j.cclet.2024.110317 shu

PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity

Yang Liu ^{a, 1} ,
Jing Liang ^{a, 1} ,
Mengzhu Zheng ^{c, 1} ,
Haoze Song ^a ,
Lixia Chen ^{a, *,} ,
Hua Li ^{a, b, *,}

a.
Key Laboratory of Structure-Based Drug Design & Discovery, Wuya College of Innovation, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
b.
Fujian Key Laboratory of Chinese Materia Medica, Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
c.
School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

syzyclx@163.com

lihua@fjtcm.edu.cn

Received Date: 23 April 2024
Revised Date: 3 August 2024
Accepted Date: 5 August 2024
Available Online: 6 August 2024

Figures(5)

Programmed cell death protein 1/programmed cell death 1 ligand 1(PD-1/PD-L1) protein-protein interaction represents an appealing target for cancer therapy. Several antibody drugs have been developed to target this interaction, but they are less effective in the treatment of melanoma. To overcome the limitations, the first proteolysis-targeting chimeric (PROTAC) small molecules simultaneously targeting PD-L1 and Src homology phosphotyrosyl phosphatase 2 (SHP2) were designed. By employment of PD-1/PD-L1 inhibitors BMS01 or BMS-37, SHP2 inhibitor SHP099 and E3 ligase ligands, a series of potent PD-L1 and SHP2 dual PROTACs were synthesized. The most promising compounds BS-7C-V2 and BS327V2 efficiently induced PD-L1 and SHP2 degradation and demonstrated significantly improved immune potency in B16-F10 and A375 cell lines. More importantly, the efficacy of BS-7C-V2 and BS327V2 in a B16-F10 transplanted mouse model was further evaluated based on their degradation ability in vivo. Taken together, our work qualifies the new dual PROTACs as a potent degrader of PD-L1 and SHP2. The biological and mechanism investigations with BS-7C-V2 and BS327V2 prove that dual PROTACs can play an anti-tumor role in vivo and in vitro, and can provide a new therapeutic strategy for melanoma.
- PD-L1,
- SHP2,
- PROTACs,
- Dual PROTACs,
- Degrader,
- Melanoma
1. [1]
  B.D. Curti, M.B. Faries. New Engl. J. Med. 384 (2021) 2229–2240. doi: 10.1056/nejmra2034861
2. [2]
  J.D. Wolchok, V. Chiarion-Sileni, R. Gonzalez et al., J. Clin. Oncol. 40 (2022) 127–137. doi: 10.1200/jco.21.02229
3. [3]
  M. Sznol. Cancer J. 20 (2014) 290–295. doi: 10.1097/PPO.0000000000000056
4. [4]
  R.S. Herbst, J.C. Soria, M. Kowanetz et al., Nature 515 (2014) 563–567. doi: 10.1038/nature14011
5. [5]
  X. Zhou, Z. Yao, H. Bai et al., Lancet Oncol. 22 (2021) 1265–1274. doi: 10.1016/S1470-2045(21)00333-8
6. [6]
  D. Imbody, K. Arce, H.S. Solanki et al., J. Thorac. Oncol. 19 (2024) 18–24. doi: 10.1016/j.jtho.2023.08.009
7. [7]
  M. Zhao, W. Guo, Y. Wu et al., Acta Pharm. Sin. B 9 (2019) 304–315. doi: 10.1016/j.apsb.2018.08.009
8. [8]
  M. Wu, Q. Huang, Y. Xie et al., J. Hematol. Oncol. 15 (2022) 24. doi: 10.24294/sf.v5i1.1617
9. [9]
  M. Zheng, J. Huo, X. Gu et al., J. Med. Chem. 64 (2021) 7839–7852. doi: 10.1021/acs.jmedchem.1c00649
10. [10]
  M. Zheng, Y. Liu, C. Wu et al., Bioorg. Chem. 110 (2021) 104788. doi: 10.1016/j.bioorg.2021.104788
11. [11]
  M. Wang, J. Lu, M. Wang et al., J. Med. Chem. 63 (2020) 7510–7528. doi: 10.1021/acs.jmedchem.0c00471
12. [12]
  Y. Liu, M. Zheng, Z. Ma et al., Chin. Chem. Lett. 34 (2023) 107762. doi: 10.1016/j.cclet.2022.107762
13. [13]
  B. Cheng, Y. Ren, H. Cao et al., Eur. J. Med. Chem. 199 (2020) 112377. doi: 10.1016/j.ejmech.2020.112377
14. [14]
  Y. Zhao, Y. Jia, T. Shi et al., Carcinogenesis 40 (2019) 1132–1141.
15. [15]
  Z. Yang, Z. Liu, C. Xu et al., Bioorg. Chem. 139 (2023) 106740. doi: 10.1016/j.bioorg.2023.106740
16. [16]
  J. Weber, M. Mandala, M. Del Vecchio et al., N. Engl. J. Med. 377 (2017) 1824–1835. doi: 10.1056/NEJMoa1709030
17. [17]
  J. Brahmer, S. Tykodi, L. Chow et al., N. Engl. J. Med. 366 (2012) 2455–2465. doi: 10.1056/NEJMoa1200694
18. [18]
  G. Hartley, L. Chow, D. Ammons et al., Cancer Immunol. Res. 6 (2018) 1260–1273. doi: 10.1158/2326-6066.cir-17-0537
19. [19]
  J. Yu, A. Zhuang, X. Gu et al., Cell Discov. 9 (2023) 33.
20. [20]
  Y. Wang, L. Su, M. Morin et al., Proc. Natl. Acad. Sci. U. S. A. 115 (2018) E8698–706.
21. [21]
  A. Drilon, M. Sharma, M. Johnson et al., Cancer Discov. 13 (2023) 1789–1801. doi: 10.1158/2159-8290.cd-23-0361
22. [22]
  D. Chen, H. Barsoumian, L. Yang et al., Cancer Immunol. Res. 8 (2020) 883–894. doi: 10.1158/2326-6066.cir-19-0744
23. [23]
  W. Su, M. Tan, Z. Wang et al., Angew. Chem. Int. Ed. 62 (2023) e202218128. doi: 10.1002/anie.202218128
24. [24]
  X. Han, W. Wei, Y. Sun. Acta Mate. Med. 1 (2022) 244–259.
25. [25]
  Y. Jing, C. Zuo, Y. Du et al., Chin. Chem. Lett. 34 (2023) 107781. doi: 10.1016/j.cclet.2022.107781
1. [1]
  Yang Liu , Yan Liu , Kaiyin Yang , Zhiruo Zhang , Wenbo Zhang , Bingyou Yang , Hua Li , Lixia Chen . A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2. Chinese Chemical Letters, 2024, 35(8): 109264-. doi: 10.1016/j.cclet.2023.109264
2. [2]
  Ting Pan , Dinghu Zhang , Guomei You , Xiaoxia Wu , Chenguang Zhang , Xinyu Miao , Wenzhi Ren , Yiwei He , Lulu He , Yuanchuan Gong , Jie Lin , Aiguo Wu , Guoliang Shao . PD-L1 targeted iron oxide SERS bioprobe for accurately detecting circulating tumor cells and delineating tumor boundary. Chinese Chemical Letters, 2025, 36(1): 109857-. doi: 10.1016/j.cclet.2024.109857
3. [3]
  Si Ha , Jiacheng Zhu , Hua Xiang , Guoshun Luo . Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives. Chinese Chemical Letters, 2024, 35(8): 109192-. doi: 10.1016/j.cclet.2023.109192
4. [4]
  Ling Yang , Min Ren , Jie Wang , Liming He , Shanshan Wu , Shuai Yang , Wei Zhao , Hao Cheng , Xiaoming Zhou , Maling Gou . A non-viral gene therapy for melanoma by staphylococcal enterotoxin A. Chinese Chemical Letters, 2024, 35(5): 108822-. doi: 10.1016/j.cclet.2023.108822
5. [5]
  Dexuan Xiao , Tianyu Chen , Tianxu Zhang , Sirong Shi , Mei Zhang , Xin Qin , Yunkun Liu , Longjiang Li , Yunfeng Lin . Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib. Chinese Chemical Letters, 2024, 35(4): 108602-. doi: 10.1016/j.cclet.2023.108602
6. [6]
  Zheyi Li , Xiaoyang Liang , Zitong Qiu , Zimeng Liu , Siyu Wang , Yue Zhou , Nan Li . Ion-interferential cell cycle arrest for melanoma treatment based on magnetocaloric bimetallic-ion sustained release hydrogel. Chinese Chemical Letters, 2024, 35(11): 109592-. doi: 10.1016/j.cclet.2024.109592
7. [7]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
8. [8]
  Yueying Yang , Huiru Xie , Xinbo Yu , Yang Liu , Hui Wang , Hua Li , Lixia Chen . Design, synthesis and evaluation of the first DYRK1A degrader for promoting the proliferation of pancreatic β-cells. Chinese Chemical Letters, 2024, 35(11): 109570-. doi: 10.1016/j.cclet.2024.109570
9. [9]
  Yu Qin , Mingyang Huang , Chenlu Huang , Hannah L. Perry , Linhua Zhang , Dunwan Zhu . O₂-generating multifunctional polymeric micelles for highly efficient and selective photodynamic-photothermal therapy in melanoma. Chinese Chemical Letters, 2024, 35(7): 109171-. doi: 10.1016/j.cclet.2023.109171
10. [10]
  Yulong Shi , Fenbei Chen , Mengyuan Wu , Xin Zhang , Runze Meng , Kun Wang , Yan Wang , Yuheng Mei , Qionglu Duan , Yinghong Li , Rongmei Gao , Yuhuan Li , Hongbin Deng , Jiandong Jiang , Yanxiang Wang , Danqing Song . Chemical construction and anti-HCoV-OC43 evaluation of novel 10,12-disubstituted aloperine derivatives as dual cofactor inhibitors of TMPRSS2 and SR-B1. Chinese Chemical Letters, 2024, 35(5): 108792-. doi: 10.1016/j.cclet.2023.108792
11. [11]
  Xiaofei NIU , Ke WANG , Fengyan SONG , Shuyan YU . Self-assembly of [Pd₆(L)₄]⁸⁺-type macrocyclic complexes for fluorescent sensing of HSO₃^-. Chinese Journal of Inorganic Chemistry, 2024, 40(7): 1233-1242. doi: 10.11862/CJIC.20240057
12. [12]
  Xiaoyu Zhao , Kai Gao , Sen Xue , Wei Ran , Rui Liu . Synergistic effects of oxygen vacancies and Pd single atoms on Pd@TiO_2−x for efficient HER catalysis. Chinese Chemical Letters, 2025, 36(6): 110309-. doi: 10.1016/j.cclet.2024.110309
13. [13]
  Miao-Miao Chen , Min-Ling Zhang , Xiao Song , Jun Jiang , Xiaoqian Tang , Qi Zhang , Xiuhua Zhang , Peiwu Li . Smartphone-assisted electrochemiluminescence imaging test strips towards dual-signal visualized and sensitive monitoring of aflatoxin B1 in corn samples. Chinese Chemical Letters, 2025, 36(1): 109785-. doi: 10.1016/j.cclet.2024.109785
14. [14]
  Yuhao Guo , Na Li , Tingjiang Yan . Tandem catalysis for photoreduction of CO2 into multi-carbon fuels on atomically thin dual-metal phosphochalcogenides. Chinese Journal of Structural Chemistry, 2024, 43(7): 100320-100320. doi: 10.1016/j.cjsc.2024.100320
15. [15]
  Tinghui Yang , Min Kuang , Jianping Yang . Mesoporous CuCe dual-metal catalysts for efficient electrochemical reduction of CO2 to methane. Chinese Journal of Structural Chemistry, 2024, 43(8): 100350-100350. doi: 10.1016/j.cjsc.2024.100350
16. [16]
  Yuan Teng , Zichun Zhou , Jinghua Chen , Siying Huang , Hongyan Chen , Daibin Kuang . Dual atom-bridge effect promoting interfacial charge transfer in 2D/2D Cs₃Bi₂Br₉/BiOBr epitaxial heterojunction for efficient photocatalysis. Chinese Chemical Letters, 2025, 36(2): 110430-. doi: 10.1016/j.cclet.2024.110430
17. [17]
  Zhenchun Yang , Bixiao Guo , Zhenyu Hu , Kun Wang , Jiahao Cui , Lina Li , Chun Hu , Yubao Zhao . Molecular engineering towards dual surface local polarization sites on poly(heptazine imide) framework for boosting H₂O₂ photo-production. Chinese Chemical Letters, 2024, 35(8): 109251-. doi: 10.1016/j.cclet.2023.109251
18. [18]
  Mengli Xu , Zhenmin Xu , Zhenfeng Bian . Achieving Ullmann coupling reaction via photothermal synergy with ultrafine Pd nanoclusters supported on mesoporous TiO2. Chinese Journal of Structural Chemistry, 2024, 43(7): 100305-100305. doi: 10.1016/j.cjsc.2024.100305
19. [19]
  Gengchen Guo , Tianyu Zhao , Ruichang Sun , Mingzhe Song , Hongyu Liu , Sen Wang , Jingwen Li , Jingbin Zeng . Au-Fe₃O₄ dumbbell-like nanoparticles based lateral flow immunoassay for colorimetric and photothermal dual-mode detection of SARS-CoV-2 spike protein. Chinese Chemical Letters, 2024, 35(6): 109198-. doi: 10.1016/j.cclet.2023.109198
20. [20]
  Guangchang Yang , Shenglong Yang , Jinlian Yu , Yishun Xie , Chunlei Tan , Feiyan Lai , Qianqian Jin , Hongqiang Wang , Xiaohui Zhang . Regulating local chemical environment in O3-type layered sodium oxides by dual-site Mg²⁺/B³⁺ substitution achieves durable and high-rate cathode. Chinese Chemical Letters, 2024, 35(9): 109722-. doi: 10.1016/j.cclet.2024.109722

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(152)
HTML views(5)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142